THE MEPHENYTOIN (CYTOCHROME-P450 2C-19) AND DEXTROMETHORPHAN (CYTOCHROME-P450 2D6) POLYMORPHISMS IN SAUDI-ARABIANS AND FILIPINOS

被引:0
作者
EVANS, DAP [1 ]
KRAHN, P [1 ]
NARAYANAN, N [1 ]
机构
[1] KING FAISAL SPECIALIST HOSP & RES CTR,RIYADH 11211,SAUDI ARABIA
来源
PHARMACOGENETICS | 1995年 / 5卷 / 02期
关键词
SAUDI ARABIA; POLYMORPHISM (GENETICS); MEPHENYTOIN; DEXTROMETHORPHAN;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Hitherto no estimate has been available of the genetic polymorphisms of S-mephenytoin hydroxylation in the Saudi Arabian or any other Middle Eastern population, A total of 102 healthy Saudi Arabian volunteer subjects were tested simultaneously with mephenytoin and dextromethorphan. Two poor metabolizers of S-mephenytoin and two poor metabolizers of dextromethorphan were found. Also 55 healthy Filipino volunteer subjects were tested and 13 found to be poor metabolizers of S-mephenytoin, whilst none were found to be poor metabolizers of dextromethorphan, The Saudi Arabian population thus appears to resemble Europeans in the frequency of poor metabolizers of S-mephenytoin, but resembles Orientals in the frequency of poor metabolizers of dextromethorphan. The Filipino sample as expected resembles other Oriental samples in the frequencies of poor metabolizers of both drugs.
引用
收藏
页码:64 / 71
页数:8
相关论文
共 40 条
[21]   GENETIC-POLYMORPHISM OF MEPHENYTOIN P(4')-HYDROXYLATION - DIFFERENCE BETWEEN ORIENTALS AND CAUCASIANS [J].
JURIMA, M ;
INABA, T ;
KADAR, D ;
KALOW, W .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (04) :483-487
[22]   POLYMORPHISM OF DEBRISOQUINE AND MEPHENYTOIN HYDROXYLATION AMONG ESTONIANS [J].
KIIVET, RA ;
SVENSSON, JO ;
BERTILSSON, L ;
SJOQVIST, F .
PHARMACOLOGY & TOXICOLOGY, 1993, 72 (02) :113-115
[23]   PHARMACOGENETICS OF MEPHENYTOIN - A NEW DRUG HYDROXYLATION POLYMORPHISM IN MAN [J].
KUPFER, A ;
PREISIG, R .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (06) :753-759
[24]   DEBRISOQUIN AND MEPHENYTOIN HYDROXYLATION PHENOTYPES AND CYP2D6 GENOTYPE IN PATIENTS TREATED WITH NEUROLEPTIC AND ANTIDEPRESSANT AGENTS [J].
LLERENA, A ;
HERRAIZ, AG ;
COBALEDA, J ;
JOHANSSON, I ;
DAHL, ML .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (06) :606-611
[25]   POPULATION AND FAMILIAL STUDY OF THE DEFECTIVE ALICYCLIC HYDROXYLATION OF DEBRISOQUINE AMONG EGYPTIANS [J].
MAHGOUB, A ;
IDLE, JR ;
SMITH, RL .
XENOBIOTICA, 1979, 9 (01) :51-56
[26]   SCLERODERMA IS ASSOCIATED WITH DIFFERENCES IN INDIVIDUAL ROUTES OF DRUG-METABOLISM - A STUDY WITH DAPSONE, DEBRISOQUIN, AND MEPHENYTOIN [J].
MAY, DG ;
BLACK, CM ;
OLSEN, NJ ;
CSUKA, ME ;
TANNER, SB ;
BELLINO, L ;
PORTER, JA ;
WILKINSON, GR ;
BRANCH, RA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (03) :286-295
[27]   INTERETHNIC DIFFERENCES IN GENETIC-POLYMORPHISM OF DEBRISOQUIN AND MEPHENYTOIN HYDROXYLATION BETWEEN JAPANESE AND CAUCASIAN POPULATIONS [J].
NAKAMURA, K ;
GOTO, F ;
RAY, WA ;
MCALLISTER, CB ;
JACQZ, E ;
WILKINSON, GR ;
BRANCH, RA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (04) :402-408
[28]  
POLLOCK BG, 1991, EUR J CLIN PHARMACOL, V40, P609
[29]   S-MEPHENYTOIN HYDROXYLATION PHENOTYPES IN A SWEDISH POPULATION DETERMINED AFTER COADMINISTRATION WITH DEBRISOQUIN [J].
SANZ, EJ ;
VILLEN, T ;
ALM, C ;
BERTILSSON, L .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (05) :495-499
[30]   POLYMORPHIC 4-HYDROXYLATION OF DEBRISOQUINE IN A TURKISH POPULATION [J].
SARDAS, S ;
PONTIN, J ;
IDLE, JR .
PHARMACOGENETICS, 1991, 1 (02) :123-124